OREGON HEALTH & SCIENCE UNIVERSITY - CENTRAL LABORATORY FOR PHARMACOKINETIC/PHARMACODYNAMIC EVALUATION OF LEVONORGESTREL BUTANOATE FOR FEMALE CONTRACEPTION

PIID: 75N94021F00001

Signed Date: Jan 30, 2026Effective Date: Feb 9, 2021End Date: Closes in 33 days

Award $

$557K

Vendor

OREGON HEALTH & SCIENCE UNIVERSITY

NAICS

541714

Signed Date

Jan 30, 2026

Key Details

Dollars Obligated

$557,412

Base & All Options

$112,619

Awarding Agency

Awarding Sub-Agency

National Institutes of Health

NAICS Code

Product Service Code

AN12 - HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH

Extent Competed

FULL AND OPEN COMPETITION

Number of Offers

Place of Performance

PORTLAND, OR, 972393098, CD-OR-01

CENTRAL LABORATORY FOR PHARMACOKINETIC/PHARMACODYNAMIC EVALUATION OF LEVONORGESTREL BUTANOATE FOR FEMALE CONTRACEPTION

On Jan 30, 2026, Department of Health and Human Services obligated $557,412 to OREGON HEALTH & SCIENCE UNIVERSITY for central laboratory for pharmacokinetic/pharmacodynamic evaluation of levonorgestrel butanoate for female contraception. The award is classified under NAICS 541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) and issued as a cost no fee contract. Competition extent: full and open competition with 1 offer received. Performance is located in PORTLAND, OR. The contract is scheduled through Jul 14, 2026 — approximately 1 months remaining.